IDO1 and acute myeloid leukemia: Our previous work in AML demonstrated that IDO1 mediates the conversion of naive CD4+CD25− T cells into fully competent Tregs, and that leukemic DCs inhibit the induction of leukemia-specific T cells via IDO1 (10, 19).